share_log

藥師幫:翌日披露報表

YSB: Next Day Disclosure Return

HKEX ·  Sep 5, 2024 18:06

Summary by Moomoo AI

藥師幫股份有限公司(YSB)於2024年9月5日根據其2019年股份激勵計劃,向董事發行了1,000,000股新股份。該次股份發行後,公司的已發行股份總數由641,998,495股增加至642,998,495股,增幅為0.15576%。每股的發行價為HKD 3.11472。公司確認該次股份發行已獲董事會正式授權批准,並遵守所有適用的上市規則、法律及其他監管規定。股份發行完成後,公司已收取全部應得款項,並已履行所有上市資格項下的先決條件。
藥師幫股份有限公司(YSB)於2024年9月5日根據其2019年股份激勵計劃,向董事發行了1,000,000股新股份。該次股份發行後,公司的已發行股份總數由641,998,495股增加至642,998,495股,增幅為0.15576%。每股的發行價為HKD 3.11472。公司確認該次股份發行已獲董事會正式授權批准,並遵守所有適用的上市規則、法律及其他監管規定。股份發行完成後,公司已收取全部應得款項,並已履行所有上市資格項下的先決條件。
Pharmacist Assistant Limited (YSB) issued 1,000,000 new shares to the directors on September 5, 2024 under its 2019 stock incentive plan. After the share issuance, the total number of issued shares of the company increased from 641,998,495 shares to 642,998,495 shares, an increase of 0.15576%. The issue price per share is HKD 3.11472. The company confirms that the share issuance has been formally authorized and approved by the board of directors, and complies with all applicable listing rules, laws, and other regulatory requirements. After the completion of the share issuance, the company has received all the proceeds due and has fulfilled all the prerequisites under the listing qualifications.
Pharmacist Assistant Limited (YSB) issued 1,000,000 new shares to the directors on September 5, 2024 under its 2019 stock incentive plan. After the share issuance, the total number of issued shares of the company increased from 641,998,495 shares to 642,998,495 shares, an increase of 0.15576%. The issue price per share is HKD 3.11472. The company confirms that the share issuance has been formally authorized and approved by the board of directors, and complies with all applicable listing rules, laws, and other regulatory requirements. After the completion of the share issuance, the company has received all the proceeds due and has fulfilled all the prerequisites under the listing qualifications.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more